04 Nov, EOD - Indian

SENSEX 78782.24 (-1.18)

Nifty 50 23995.35 (-1.27)

Nifty Bank 51215.25 (-0.89)

Nifty IT 40421.8 (-0.03)

Nifty Midcap 100 55784.55 (-1.26)

Nifty Next 50 69418.25 (-1.40)

Nifty Pharma 22638.3 (-0.74)

Nifty Smallcap 100 18424.65 (-1.97)

04 Nov, EOD - Global

NIKKEI 225 38053.67 (-2.63)

HANG SENG 20567.52 (0.30)

S&P 5755.25 (-0.26)

Login/Signup
LOGIN HERE
Cancel

RHI Magnesita India Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 534076 | NSE Symbol : RHIM | ISIN : INE743M01012 | Industry : Refractories |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
29-Jul-2024 14-Aug-2024 Quarterly Results Rhi Magnesita India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Intimation regarding meeting of Board of Directors of RHI Magnesita India Limited is scheduled to be held on Wednesday 14 August 2024 inter alia to consider approve and take on record unaudited financial results (Standalone & Consolidated) of the Company for the quarter ended 30 June 2024. The financial results shall be subject to limited review by the Statutory Auditors of the Company.
08-May-2024 29-May-2024 Accounts Rhi Magnesita India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve and take on record audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31 2024 Rhi Magnesita India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve For recommendation of Final Dividend for the financial year ended March 31, 2024 (As Per BSE Announcement Dated on 17.05.2024) Recommendation of final dividend of Rs. 2.50 per equity share Approval of audited standalone and consolidated financial statements of the Company for quarter and financial year ended 31 March 2024, recommendation of final dividend and revision of Corporate Social Responsibility policy and Risk management policy Read less.. (As Per BSE Announcement Dated on 29/05/2024)
29-Apr-2024 29-Apr-2024 Change in Other Executives Appointment of Chief Financial Officer w.e.f. May 1, 2024
15-Jan-2024 13-Feb-2024 Quarterly Results Rhi Magnesita India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Inter alia to consider approve and take on record the unaudited standalone & consolidated financial results of the Company for the quarter and nine months ended 31 December 2023 In reference to Company''s letter dated 15 January 2024 with regard to intimation for convening meeting of Board of Directors of the Company and pursuant to Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, {''Listing Regulations''), we wish to inform you that the Board of Directors of the Company at the meeting held today has approved the Unaudited Consolidated and Standalone Financial Results for the quarter and nine months ended 31 December 2023. Further, we would like to state that Price Waterhouse, Chartered Accountants LLP, Statutory Auditors of the Company have issued limited review reports on the above said financial results. Financials enclosed (As Per BSE Announcement Dated on 13/02/2024)
08-Feb-2024 08-Feb-2024 Scheme of Amalgamation Enclosed Intimation regarding Scheme of Merger/ Amalgamation of RHI Magnesita Seven Refractories Limited (RHIM7) with i.e. Wholly-owned Subsidiary of RHI Magnesita India Refractories Limited (RHIMIRL) which is wholly-owned subsidiary of RHI Magnesita India Limited ('Company')
27-Oct-2023 08-Nov-2023 Quarterly Results Rhi Magnesita India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Pursuant to regulation 29(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that meeting of Board of Directors of RHI Magnesita India Limited is scheduled to be held on Wednesday 8 November 2023 inter alia to consider approve and take on record the unaudited standalone & consolidated financial results of the Company for the quarter and half year ended 30 September 2023. The financial results shall be subject to limited review by the Statutory Auditor of the Company. Further in continuation to our letter dated 29 September 2023 regarding closure of trading window for dealing in shares of the Company we hereby inform the trading window for dealing in shares of the Company shall continue to remain closed till November 10 2023 (inclusive) for all the Designated Persons of the Company and their Immediate Relatives In reference to Company's letter dated 27 October 2023 with regard to intimation for convening meeting of Board of Directors of the Company and pursuant to Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), we wish to inform you that the Board of Directors of the Company at the meeting held today has approved the Unaudited Consolidated and Standalone Financial Results for the quarter and six months ended 30 September 2023. Further, we would like to state that Price Waterhouse, Chartered Accountants LLP, Statutory Auditors of the Company have issued limited review reports on the above said financial results. Results enclosed (As per BSE Announcement Dated on 08/11/2023)
26-Jul-2023 10-Aug-2023 Quarterly Results Rhi Magnesita India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve Pursuant to regulation 29(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that meeting of Board of Directors of RHI Magnesita India Limited is scheduled to be held on Thursday 10 August 2023 inter alia to consider approve and take on record the unaudited consolidated & standalone financial results of the Company for the quarter ended 30 June 2023. The financial results shall be subjected to limited review by the Statutory Auditor of the Company. Further in continuation to our letter dated 30 June 2023 regarding closure of trading window for dealing in shares of the Company we hereby inform the trading window for dealing in shares of the Company shall continue to remain closed till 12 August 2023 (inclusive) for all the Designated Persons of the Company and their Immediate Relatives RHI Magnesita India Limited has informed BSE about Board Meeting to be held on 10 Aug 2023 to consider financial statements for the period ended June 2023. Financial results / Other business. In reference to Company''s letter dated 26 July 2023, intimating about conduction of the meeting of Board of Directors of our Company and pursuant to regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015 ('Listing Regulations'), we wish to inform that the Board of Directors of our company met today and approved the Unaudited Consolidated & Standalone Financial Results for the quarter ended 30 June 2023. Further, we would like to state that Price Waterhouse Chartered Accountants LLP, Statutory Auditors of the Company, have issued limited review reports on the above said financial results. (As per BSE Announcement Dated on 10/08/2023)
16-May-2023 31-May-2023 Quarterly Results Rhi Magnesita India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Pursuant to regulation 29(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of Board of Directors of RHI Magnesita India Limited is scheduled to be held on Tuesday 30 May 2023 inter alia to i. consider approve and take on record the audited standalone financial results of the Company for the quarter and year ended 31 March 2023; ii. consider approve and take on record the audited consolidated financial results of the Company for the quarter and year ended 31 March 2023; iii. consider and recommend final dividend if any on the equity shares of the Company for the financial year ending 31 March 2023 subject to approval of the shareholders of the Company at the ensuing 13th Annual General Meeting. In reference to Company's letter dated 16 May 2023, intimating about conduction of the meeting of Board of Directors of the Company and pursuant to regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform that the Board of Directors of the Company met today and approved the following: I. Audited Consolidated & Standalone Financial Results for the quarter and year ended 31 March 2023. Further, we would like to state that Price Waterhouse Chartered Accountants LLP, Statutory Auditors of the Company, have issued audit reports on the above said financial results with unmodified opinion on the Statement. (Enclosed); II. Recommendation of final dividend of Rs. 2.50/- per Equity Share of Re. 1.00/- each of the Company which shall be paid/dispatched subject to approval of shareholders of the Company within five days from the date of declaration of such dividend in the ensuing Annual General Meeting. (As Per BSE Announcement Dated on 30.05.2023) In continuation to our letter dated 25 May 2023, and pursuant to Regulation 30(6) read with Part A of Schedule Ill of the Listing Regulations, we hereby inform you that Investors'' Conference Call post announcement of Financial Results for the fourth quarter and year ended 31 March 2023 of the Company, scheduled to be held on Tuesday, 30 May 2023, at 5:30 p.m. (IST) has been postponed. The re-scheduled meeting will be held on Wednesday 31 May 2023 at 5:30 p.m. (IST). Rest of the information in the previous intimation would remain same. (As Per BSE Announcement Dated on 30.05.2023)
06-Apr-2023 06-Apr-2023 Qualified Institutions Placements RHI MAGNESITA INDIA LTD has informed the Exchange regarding Board meeting held on April 06, 2023. Board alia, The Fund Raising Committee at its meeting held on 6th April 2023, approved the issue and allotment of 1,57,15,034 Equity Shares to 57 qualified institutional buyers at the issue price of Rs 572.70 per Equity Share, i.e. at a premium of Rs 571.70 per Equity Share, aggregating toRs 9,000 million (Rupees Nine Thousand Million), pursuant to the Issue. Pursuant to the allotment of Equity Shares in the Issue, the paid-up Equity Share capital of the Company stands increased to Rs 20,37,11,365.00 consisting of 20,37,11,365 Equity Shares of face value Rs 1 each. (See company announcement on bse website:www.bseindia.com for complete details) The Issue opened on 29 March 2023 and closed on 5 April 2023 and the same was intimated to you through our letters dated 29 March 2023 and 5 April 2023, respectively. (As Per BSE Bulletin Dated on 06.04.2023)
28-Mar-2023 01-Apr-2023 Preferential Issue Rhi Magnesita India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/04/2023 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday April 1 2023 inter alia to consider and approve the proposal for raising of funds by way of a preferential allotment by way of issue of equity shares to its promoters and / or the members of the promoter group of the Company for an aggregate amount not exceeding ? 2000 million in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 as amended and all other applicable laws as may be considered appropriate subject to the necessary government / regulatory / statutory approvals and requirements as may be required including the approval of the shareholders of the Company. amended from time to time, we wish to inform you that the Board of Directors ('Board') of RHI Magnesita India Limited (the 'Company), at its meeting held today i.e. April 1, 2023, has approved proposal for raising of funds by way of issuance of such number of equity shares having face value ?1 each ('Equity Shares') aggregating up to ? 200 Crore (Rupees Two Hundred Crore Only) on a preferential basis ('Preferential Issue'), to M/s. Dutch US Holding B.V., a promoter of the Company in accordance the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended ('SEBI ICDR Regulations') and other applicable laws, at such price as will be determined in accordance with the SEBI ICDR Regulations and other applicable regulation, if any, and subject to the approval of regulatory / statutory authorities, as applicable, and the approval of shareholders of the Company. The meeting commenced at 10:00 AM (IST) and concluded at 10:45 A.M (IST). (As Per BSE Announcement Dated on 01/04/2023)
29-Mar-2023 29-Mar-2023 EGM Qualified institutions placement of equity shares of face value of ? 1 each (the 'Equity Share(s)') by RHI Magnesita India Limited (the 'Company') under the provisions of Chapter VI of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the 'SEBI ICDR Regulations'), and Sections 42 and 62 of the Companies Act, 2013 (including the rules made thereunder), as amended (the 'Issue')
30-Jan-2023 13-Feb-2023 Quarterly Results Rhi Magnesita India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve Pursuant to regulation 29(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that meeting of Board of Directors of RHI Magnesita India Limited is scheduled to be held on Monday 13 February 2023 inter alia to consider approve and take on record the unaudited consolidated & standalone financial results of the Company for the quarter and nine months ended 31 December 2022. The financial results shall be subjected to limited review by the Statutory Auditor of the Company. Further in continuation to our letter dated 29 December 2022 regarding closure of trading window for dealing in shares of the Company we hereby inform the trading window for dealing in shares of the Company shall continue to remain closed till 15 February 2023 (inclusive) for all the Designated Persons of the Company and their Immediate Relatives. Rhi Magnesita India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve This letter is in continuation to our intimation dated 31.01.2023. We hereby further submit that Board of Directors, on 13.02.2023 , will also consider and approve raising further capital and to create, offer, issue and allot such number of equity shares, and/ or securities convertible into Equity Shares , and/ or securities linked to Equity Shares, and/ or any instrument or securities representing Equity Shares, and/ or convertible securities linked to Equity Shares (all of which are hereinafter collectively referred to as 'Securities') or any combination of Securities, by way of qualified institutions placement, further public offering and/or combination thereof as may be considered appropriate or any other permissible mode, in one or more tranches, in accordance with the SEBI ICDR, as amended, and all other applicable laws, as may be considered appropriate, subject to shareholders approval and government/ regulatory/ statutory approvals and requirements, as applicable. (As per BSE Announcement Dated on 08/02/2023) I. Unaudited Consolidated & Standalone Financial Results for 31.12.2022 II. Raising further capital in one or more tranches, for an aggregate amount not exceeding Rs. 1,500 Crores Raising further capital and to create, offer, issue and allot such number of equity shares, and/ or securities convertible into Equity Shares at the option of the Company and/ or holders of such securities, and/ or securities linked to Equity Shares, and/ or any instrument or securities representing Equity Shares, and/ or convertible securities linked to Equity Shares (all of which are hereinafter collectively referred to as 'Securities') or any combination of Securities, by way of qualified institutions placement, further public offering or any other permissible mode, in one or more tranches, for an aggregate amount not exceeding Rs. 1,500 Crores, in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 ('SEBI ICDR') and all other applicable laws, as may be considered appropriate, subject to shareholders approval and government / regulatory / statutory approvals and other requirements, as applicable. (As Per BSE Announcement Dated on 13/02/2023) Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), as amended from time to time, we would like to inform you that Mr. Rudraraju Suryanarayana Raju Venkata (DIN: 00425640) has resigned from the position of whole-time director of the Company, due to personal reason, effective from closing hours of February 13, 2023. The Board of Directors of the Company at their meeting held on Monday, February 13, 2023 have taken note of his resignation from the position of whole-time director of the Company. Unaudited Consolidated & Standalone Financial Results for the quarter and nine months ended 31 December 2022 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), as amended from time to time, we would like to inform you that Mr. Rudraraju Suryanarayana Raju Venkata (DIN: 00425640) has resigned from the position of whole-time director of the Company, due to personal reason, effective from closing hours of February 13, 2023. The Board of Directors of the Company at their meeting held on Monday, February 13, 2023 have taken note of his resignation from the position of whole-time director of the Company. (As Per BSE Announcement Dated on 14.02.2023) Qualified institutions placement of equity shares of face value of ? 1 each (the 'Equity Share(s)') by RHI Magnesita India Limited (the 'Company') under the provisions of Chapter VI of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the 'SEBI ICDR Regulations'), and Sections 42 and 62 of the Companies Act, 2013 (including the rules made thereunder), as amended (the 'Issue') (As per BSE Announcement Dated on 29/03/2023)
29-Dec-2022 05-Jan-2023 Preferential Issue Rhi Magnesita India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/01/2023 inter alia to consider and approve Pursuant to regulation 29(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 and in continuation to intimations dated 19 November 2022 regarding issue of shares to DBRL and 22 December 2022 relating to proceedings of Extra Ordinary General for approval of shareholders on issuance of shares we hereby inform you that meeting of Board of Directors of RHI Magnesita India Limited is scheduled to be held on Wednesday 4 January 2023 inter alia to issue and allot 27000000 equity shares of the Company on preferential basis to DBRL. The Board Meeting to be held on 04/01/2023 has been revised to 05/01/2023 The Board Meeting to be held on 04/01/2023 has been revised to 05/01/2023 (As Per BSE Announcement Dated on 30/12/2022) Pursuant to Regulation 30 of SEBI (LODR) and in continuation to our earlier intimation dated 19 November 2022, approval received from members of the Company and In-principle approval received from BSE Limited and National Stock Exchange of India Limited, we wish to inform you that the, the Board of Directors of the Company in their meeting held today i.e. 5 January 2023 have inter-alia approved the following (As Per BSE Announcement dated on 05.01.2023)
15-Nov-2022 19-Nov-2022 Preferential Issue Rhi Magnesita India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/11/2022 inter alia to consider and approve In accordance with the captioned regulations of SEBI LODR and other applicable provisions we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday November 19 2022 to consider the issue of equity shares of the Company by way of preferential allotment in accordance with the applicable laws and shall be subject to such regulatory/ statutory approvals as may be required including the approval of the shareholders of the Company. Further we wish to inform you that the Company proposes to seek Members approval for the said proposal in due course by way of Postal Ballot/ Extraordinary General Meeting. For the purpose of above and as per the Companys Internal Code of Conduct to Regulate Monitor and Report Trading by Designated Persons Trading Window for dealing in the securities of the Company has been closed from Tuesday November 152022 till Tuesday November 222022 (both days inclusive).
27-Oct-2022 09-Nov-2022 Quarterly Results Quarterly Results Rhi Magnesita India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 ,inter alia, to consider and approve Pursuant to regulation 29(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of Board of Directors of RHI Magnesita India Limited is scheduled to be held on Wednesday, 9 November 2022, inter alia, to consider, approve and take on record the unaudited consolidated & standalone financial results of the Company for the quarter and half year ended 30 September 2022. The financial results shall be subjected to limited review by the Statutory Auditor of the Company. Further, in continuation to our letter dated 30 September 2022 regarding closure of trading window for dealing in shares of the Company, we hereby inform the trading window for dealing in shares of the Company shall continue to remain closed till November 11, 2022 (inclusive), for all the Designated Persons of the Company and their Immediate Relatives. (As Per BSE Announcement Dated on 26.10.2022) In reference to Company's letter dated 26 October 2022, intimating about conduction of the meeting of Board of Directors of our Company and pursuant to regulations 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015 ('Listing Regulations'), we wish to inform that the Board of Directors of our Company met today and approved the Unaudited Consolidated & Standalone Financial Results for the quarter and half year ended 30 September 2022. (As Per BSE Announcement Dated on 09/11/2022)
1 2